Special Lecture: Bespoke CRISPR Gene Editing Therapies at Nationwide Scale: an Actionable Path

Date: 7 July 2025

Time: 16:00 (please be seated by 15:55)

Venue: Blakemore Lecture Theatre, Sherrington Building

This Special Lecture is hosted by Professor Matthew Wood

on behalf of the

Departments of Paediatrics & Physiology, Anatomy and Genetics, and the Kavli Institute for Nanoscience Discovery

Professor Fyodor Urnov’s talk is entitled “Bespoke CRISPR Gene Editing Therapies at Nationwide Scale: an Actionable Path”

Biography:

Fyodor Urnov is the Director for Technology and Translation at the Innovative Genomics Institute and a Professor of Molecular Therapeutics in the Department of Molecular and Cell Biology at UC Berkeley. He co-developed the toolbox of human genome and epigenome editing, co-named genome editing, and was on the team that advanced all of its first-in-human applications to the clinic. He also led the effort that identified the genome editing target for an approved medicine to treat sickle cell disease and beta-thalassemia. A major goal for the field of genome editing and a key focus of Fyodor’s work is expanding access to CRISPR therapies for genetic disease. As part of that effort Fyodor directs the Danaher-IGI Beacon for CRISPR Cures – a first-in-class academia-industry partnership developing and advancing to the clinic scalable CRISPR-based approaches to treat diseases of the immune system. Fyodor also leads cross-functional teams in developing and advancing to the clinic CRISPR-based approaches to treat neurodegenerative, neuroinflammatory, and infectious diseases.

This event is for Oxford University staff and students only.

Further information on https://talks.ox.ac.uk/talks/id/c81027ff-c8e3-4e30-8d8e-3bd5bdf74b31/